Chemotherapy-resistant cancer stem cells make it hard to cure many forms of the disease. Repositioning an existing drug to tackle this problem could significantly improve treatment for one form of leukaemia. See Letter p.380
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Notes
References
Prost, S. et al. Nature 525, 380–383 (2015).
Daley, G. Q., Van Etten, R. A. & Baltimore, D. Science 247, 824–830 (1990).
Kranc, K. R. et al. Cell Stem Cell 5, 659–665 (2009).
Ito, K. et al. Nature 453, 1072–1078 (2008).
Bellodi, C. et al. J. Clin. Invest. 119, 1109–1123 (2009).
Pemovska, T. et al. Nature 519, 102–105 (2015).
Prost, S. et al. J. Clin. Invest. 118, 1765–1775 (2008).
Author information
Authors and Affiliations
Corresponding authors
Related links
Rights and permissions
About this article
Cite this article
Holyoake, T., Vetrie, D. Repositioned to kill stem cells. Nature 525, 328–329 (2015). https://doi.org/10.1038/nature15213
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature15213
